can semaglutide cause high potassium Does Mounjaro Lower Levels? Evidence and Monitoring Guidance – Bolt Pharmacy Semaglutide as a GLP-1 Agonist:

Compared to usual care, participants who used GLP-1RAs had a lower risk of: substance use and psychotic disorders seizures neurocognitive disorders including Alzheimers disease and dementia infectious illnesses several respiratory conditions coagulation and cardiometabolic disorders, including deep vein thrombosis, pulmonary embolism, stroke, cardiac arrest, heart failure and myocardial infarction

Is it fair to say that if one is interested in exploring the use of peptides for what you refer to as performance medicine, mental, physical health, and performance falls underneath that, to essentially only put peptides into their body, maybe even on their body surface, that they're obtaining from a physician who's obtained the peptides from a compounding pharmacy

Clinical Evidence: Semaglutide A1C Reduction Data Landmark trials including SUSTAIN-6 and SUSTAIN-7 demonstrated that semaglutide-treated patients achieved A1C reductions ranging from 1.5% to 2.0% compared to placebo

More recently, Mounjaro (the injection I was prescribed) has been released for similar purposes